ArticleBlood science (Baltimore, Md.)2022

The impact of venetoclax based regimens in the preemptive of measurable residual disease in acute myeloid leukemia.

Qiuyun Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.